Cranbrook Wealth Management’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$688K Hold
3,267
0.13% 77
2026
Q1
$722K Hold
3,267
0.15% 70
2025
Q4
$828K Buy
3,267
+1,239
+61% +$311K 0.16% 68
2025
Q3
$502K Hold
2,028
0.1% 80
2025
Q2
$487K Hold
2,028
0.1% 78
2025
Q1
$460K Sell
2,028
-131
-6% -$28.8K 0.11% 78
2024
Q4
$444K Buy
2,159
+90
+4% +$19.7K 0.1% 85
2024
Q3
$502K Hold
2,069
0.11% 78
2024
Q2
$454K Buy
+2,069
New +$449K 0.11% 77
2021
Q2
Sell
-48
Closed -$9K 380
2021
Q1
$9K Buy
+48
New +$8.9K ﹤0.01% 302

Other funds holding STE

Cranbrook Wealth Management's STE Position: Q2 2026 in Review

Cranbrook Wealth Management held its Steris (STE) position steady in Q2 2026 at 3,267 shares worth $688K. The position accounts for 0.13% of the portfolio, ranked #77.

Cranbrook Wealth Management first reported a position in STE in Q1 2021 and has held it in 10 quarters since. The position peaked at $828K in Q4 2025. 830 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Cranbrook Wealth Management held 3,267 shares of Steris worth $688K as of Q2 2026.
  • Cranbrook Wealth Management left its Steris share count unchanged in Q2 2026.
  • Steris made up 0.13% of Cranbrook Wealth Management's portfolio in Q2 2026, its #77 holding.
  • Cranbrook Wealth Management first reported a position in Steris in Q1 2021 and has held it in 10 quarters since.
  • Cranbrook Wealth Management's Steris position peaked at $828K in Q4 2025.
  • 830 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Cranbrook Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.